Tocladesine
- Level
- Commodity
- Parent
- 51111600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51111653This classification denotes a purine antagonist and differentiation inducer with the molecular formula C10H11ClN5O6P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BQ94Z7E5OR, chemically known as 8-chloroadenosine 3,5-monophosphate but generally known as tocladesine, which bears US NIH Compound Identifier 100299. Most nations schedule tocladesine under HS 29349990 and SITC 51579. As of Q4 2014, TOCLADESINE remains the US FDA Preferred Term for this commodity. Tocladesine bears US NLM identifiers UMLS ID C0050063 and NCI Concept Code C2571. SMILES: C1C2C(C(C(O2)N3C4=C(C(=NC=N4)N)N=C3CL)O)OP(=O)(O1)O.
Same parent
Under 51111600 · 55Activities that produce or sell this
KBLI · 8Inherited from family 51110000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.